1. Home
  2. NYXH vs WNEB Comparison

NYXH vs WNEB Comparison

Compare NYXH & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYXH
  • WNEB
  • Stock Information
  • Founded
  • NYXH 2009
  • WNEB 1853
  • Country
  • NYXH Belgium
  • WNEB United States
  • Employees
  • NYXH N/A
  • WNEB N/A
  • Industry
  • NYXH Medical/Dental Instruments
  • WNEB Savings Institutions
  • Sector
  • NYXH Health Care
  • WNEB Finance
  • Exchange
  • NYXH Nasdaq
  • WNEB Nasdaq
  • Market Cap
  • NYXH 185.5M
  • WNEB 195.7M
  • IPO Year
  • NYXH 2021
  • WNEB N/A
  • Fundamental
  • Price
  • NYXH $6.48
  • WNEB $11.47
  • Analyst Decision
  • NYXH Strong Buy
  • WNEB Buy
  • Analyst Count
  • NYXH 3
  • WNEB 2
  • Target Price
  • NYXH $15.00
  • WNEB $11.00
  • AVG Volume (30 Days)
  • NYXH 83.5K
  • WNEB 64.1K
  • Earning Date
  • NYXH 11-05-2025
  • WNEB 10-22-2025
  • Dividend Yield
  • NYXH N/A
  • WNEB 2.42%
  • EPS Growth
  • NYXH N/A
  • WNEB N/A
  • EPS
  • NYXH N/A
  • WNEB 0.59
  • Revenue
  • NYXH $5,793,306.00
  • WNEB $76,036,000.00
  • Revenue This Year
  • NYXH $85.62
  • WNEB N/A
  • Revenue Next Year
  • NYXH $320.09
  • WNEB $7.36
  • P/E Ratio
  • NYXH N/A
  • WNEB $19.64
  • Revenue Growth
  • NYXH 2.94
  • WNEB 2.15
  • 52 Week Low
  • NYXH $4.35
  • WNEB $7.63
  • 52 Week High
  • NYXH $11.87
  • WNEB $12.80
  • Technical
  • Relative Strength Index (RSI)
  • NYXH 65.15
  • WNEB 37.66
  • Support Level
  • NYXH $4.36
  • WNEB $11.45
  • Resistance Level
  • NYXH $6.75
  • WNEB $12.08
  • Average True Range (ATR)
  • NYXH 0.32
  • WNEB 0.32
  • MACD
  • NYXH 0.27
  • WNEB -0.12
  • Stochastic Oscillator
  • NYXH 89.12
  • WNEB 9.39

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

Share on Social Networks: